Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Europe midday: Merck, Airbus lead losses as markets fall
(Sharecast News) - European stocks were firmly lower by the midday mark in Frankfurt as heavy falls in the aerospace and pharmaceuticals sectors weighed on indices across the continent. Big falls from biopharma group Merck and aerospace giant Airbus were weighing heavily on sentiment, while growing uncertainty ahead of this week's elections in France were keeping a lid on risk appetite.
"Coming off the back of a US session that had seen weakness across both the Nasdaq and S&P 500, that same downbeat tone appears to be evident in Europe despite a lack of any particularly notable economic releases this morning," said Joshua Mahony, chief market analyst at IG.
The pan-European Stoxx 600 benchmark index was 0.3% lower by lunchtime. Germany's Dax and France's Cac 40 were the worst performers of the session, down 1% and 0.6% respectively; while markets in the UK, Spain and Italy fell by a lesser amount.
Merck plummeted after the biopharma group called time on a cancer drug trial of lack of efficacy. The company stopped its trial of head and neck cancer treatment xevinapant, marking "another surprising setback for the healthcare pipeline", according to analysts at Barclays.
Airbus was out of favour after cutting its full-year earnings targets as a result of a "degraded operating environment", meaning it would only deliver around 700 aircraft this year, compared with previous guidance of 800. Annual EBITDA is now expected to be €5.5bn, down from earlier guidance of €7bn.
Sentiment in the travel and aerospace sector was also dented by news overnight that a Boeing plane operating a Korean Air flight heading for Taiwan dropped 25,000 feet in five minutes after a fault with its pressurisation system, adding to more woes for the American aircraft manufacturer.
Meanwhile, US prosecutors recommended overnight that the Department of Justice bring criminal charges against Boeing for violating a settlement related to two fatal crashes in 2018 and 2019.
Aerospace and engineering firms were all in the red in Europe, with MTU Aero Engines, Melrose, Rolls-Royce, SAFRAN, Trelleborg and Dassault Aviation all falling sharply.
London's FTSE 100 was outperforming wider European markets, falling by just 0.1% as downside was limited by gains from heavyweights Shell and BP.
Economic data was thin on the ground on Tuesday, with revisions to first-quarter GDP in Spain the only notable release. The economy expanded by 0.8% in the first three months of 2024, up from the initial estimate of 0.7% and the 0.7% growth seen in the fourth quarter - marking the strongest quarterly growth in nearly two years. The annual growth rate was also revised 10 basis points higher to 2.5%.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.